Notice2023-22624
Bulk Manufacturer of Controlled Substances Application: Curia New York, Inc
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 13, 2023
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
Curia New York, Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 197 (Friday, October 13, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 197 (Friday, October 13, 2023)]
[Notices]
[Pages 71022-71023]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-22624]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1273]
Bulk Manufacturer of Controlled Substances Application: Curia New
York, Inc
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Curia New York, Inc has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
December 12, 2023. Such persons may also file a written request for a
hearing on the application on or before December 12, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 10, 2023, Curia New York, Inc, 33 Riverside
Avenue, Rensselaer, New York 12144-2951, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana................................ 7360 I
Tetrahydrocannabinols.................... 7370 I
Amphetamine.............................. 1100 II
Lisdexamfetamine......................... 1205 II
Methylphenidate.......................... 1724 II
Pentobarbital............................ 2270 II
Codeine.................................. 8333 II
Dihydrocodeine........................... 9050 II
Oxycodone................................ 9143 II
Hydromorphone............................ 9150 II
Hydrocodone.............................. 9193 II
Meperidine............................... 9230 II
Morphine................................. 9300 II
[[Page 71023]]
Fentanyl................................. 9801 II
------------------------------------------------------------------------
The company plans to manufacture the above controlled substances as
bulk active pharmaceutical ingredients for use in product development
and for distribution to its customers. In reference to drug codes 7360
(Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to
bulk manufacture these drugs as synthetic. No other activities for
these drug codes are authorized for this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-22624 Filed 10-12-23; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on October 13, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.